2023 Category Winner for Innovation: Chugai Pharma Manufacturing Co., Ltd.

Chugai Pharmaceutical Building 48, known as FJ2, is an API facility for the manufacture of small and mid-size molecule drugs to be used for clinical development purposes. Located in the heart of Japan at a key transportation point, construction and commissioning of a new manufacturing center was completed at the Chugai Fujieda plant responsible for the supply of Active Pharmaceutical Ingredients (APIs) in August 2022.

Learn More

Subscribe to your ISPE YouTube Channel
& Click the bell for notifications.

View All Videos